Učitavanje...
Tumor-associated antigen specific CD8(+) T cells in hepatocellular carcinoma – a promising target for immunotherapy
Immunotherapy is a promising treatment option for patients with hepatocellular carcinoma (HCC). Indeed, CD8(+) T-cell responses against various tumor antigens occur in these patients. However, these antitumoral T cells show a severely impaired effector function. Several immunosuppressive mechanisms...
Spremljeno u:
| Izdano u: | Oncoimmunology |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292268/ https://ncbi.nlm.nih.gov/pubmed/25941604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.954919 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|